Exercise program for children with cancer to improve insulin sensitivity
Official title: Adapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity
Run by University Hospital, Toulouse · NCT05383092 · Data updated 2026-11-12
This study is testing if an exercise program can help improve insulin sensitivity and overall health in children with cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 18 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | July 11, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 21, 2023 |
| Trial ID | NCT05383092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5 to 18 years who are newly diagnosed with solid or hematological cancers and have a life expectancy of more than six months.
✕Probably not a fit
Patients with physical or psychological limitations that prevent participation in an exercise program, or those with certain pre-existing health conditions, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates how intense physical activity affects insulin sensitivity and other metabolic, motor, and nutritional factors in children diagnosed with cancer. Over a period of six months, participants will engage in either intense physical activities or stretching programs, with evaluations conducted at multiple intervals. The sessions will be tailored to each child's needs and abilities, taking place in the hospital or via videoconference. The goal is to determine if exercise can enhance health outcomes for these children.
Why it matters
Potential benefit: If successful, this program could significantly improve metabolic health and overall well-being in children undergoing cancer treatment.
How similar studies have gone: Previous studies have shown positive outcomes with exercise interventions in pediatric cancer patients, suggesting this approach may be beneficial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 5 and 18 years old; * have a solid cancer or hematological disease; * be treated for the first time in pediatric oncology and hematology department; * have an estimated life expectancy at diagnosis of more than 6 months. Exclusion Criteria: * present a physical and/or psychological impossibility to follow an adapted physical activity program; * have a pre-existing heart disease that is not suitable for adapted physical activities; * have a known type 1 diabetes * have an obesity defined by a body mass index greater than or equal to the International Obesity Task Force 25 threshold
Where it's running
-
PASQUET Marlène
Toulouse, France Recruiting
Study contacts
- Principal investigator: Marlène PASQUET, MD, PhD — University Hospital, Toulouse
- Study coordinator: Marlène PASQUET, MD, PhD
- Email: pasquet.m@chu-toulouse.fr
- Phone: 05 34 55 86 08
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.